首页 | 本学科首页   官方微博 | 高级检索  
检索        

疏血通注射液联合静脉用药在急性脑梗死治疗中的合理安全应用
引用本文:黎明全,谢雁鸣,赵建军.疏血通注射液联合静脉用药在急性脑梗死治疗中的合理安全应用[J].中国中药杂志,2012,37(18):2742-2743.
作者姓名:黎明全  谢雁鸣  赵建军
作者单位:中国中医科学院 博士后流动站, 北京 100700;长春中医药大学 附属医院, 吉林 长春 130021;中国中医科学院 中医临床基础医学研究所, 北京 100700;长春中医药大学 附属医院, 吉林 长春 130021
基金项目:国家"重大新药创制"科技重大专项(2009ZX09502-030)"中药上市后评价关键技术研究"
摘    要:疏血通注射液是由水蛭、地龙2种虫类中药精制而成的复方注射剂,具有明显的抗凝、促进纤溶和改善血液流变及调节血脂、细胞保护作用,已在临床获得较为广泛的应用。疏血通注射液联合其他中西药注射液治疗急性脑梗死,在临床上尚存在不规范、不合理的问题。因此,本文系统阐述疏血通注射液临床应用存在的主要问题及如何与其他中、西药注射液合理联合应用,为更加合理、安全的使用疏血通注射液,避免不良反应的发生,规范使用疏血通注射液提供参考。

关 键 词:疏血通注射液  联合用药  脑梗死  临床应用
收稿时间:2012/7/15 0:00:00

Reasonable and safe application of Shuxuetong injection and intravenous medication's combined application in acute cerebral infarction's therapy
LI Ming-quan,XIE Yan-ming and ZHAO Jian-jun.Reasonable and safe application of Shuxuetong injection and intravenous medication's combined application in acute cerebral infarction's therapy[J].China Journal of Chinese Materia Medica,2012,37(18):2742-2743.
Authors:LI Ming-quan  XIE Yan-ming and ZHAO Jian-jun
Institution:Post-doctoral Station, China Academy of Chinese Medical Sciences, Beijing 100700, China;The Affiliated Hospital to Changchun University of Traditional Chinese Medicine, ChangChun 130021, China;Institute of Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China;The Affiliated Hospital to Changchun University of Traditional Chinese Medicine, ChangChun 130021, China
Abstract:Shuxuetong injection is a kind of compound injection which is made from traditional Chinese medicine Hirudo and Pheretime,which has a clear anticoagulant,fibrinolytic promoting,blood rheology improving,blood lipids regulating and cell protecting effect,and the injection has been widely used in clinical. Especially,the injection has often been combined with other Chinese and modern medicine in the treatment of cerebral infarction disease. However,there are still many non-standard and irrational aspects in clinical practice so as to make a more reasonable and safer use of Shuxuetong injection. In order to avoid the occurrence of adverse reactions to provide a reference for regulating the use of the injection,the paper systematically expounds the Shuxuetong injection's main clinical problems and the reasonable combination.
Keywords:Shuxuetong injection  combination therapy  cerebral infarction  clinical application
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号